Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011)

Group, JCS Joint Working

doi:10.1253/circj.cj-66-0054

Cited by 135 publications

(31 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All patients gave written informed consent to participate in this study. According to the guidelines for implantation of an ICD/CRT‐D, 14 indication and purpose of implantation were determined by attending cardiologists of each center. The details of the overall study design and main results of the Nippon‐storm study have previously been published elsewhere 12,13 …”

Section: Methodsmentioning

confidence: 99%

Patient‐by‐patient basis anti‐tachycardia pacing for fast ventricular tachycardia with structural heart diseases

Chinushi¹,

Furushima²,

Saitoh³

et al. 2020

Pacing Clinical Electrophis

View full text Add to dashboard Cite

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is an important tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for fast VT has not been fully studied. Methods Using the database of Nippon‐storm study, effect of patient‐by‐patient basis ATP programming for fast VT (≥188 bpm) was assessed for the patients with structural heart diseases. Fast VTs were divided into three groups depending on heart rate (HR); Group A was 188–209 bpm, and Group‐B and Group‐C were 210‐239 bpm and ≥240 bpm, respectively. Results During a median follow‐up of 28 months, 202 fast VT episodes (209 ± 19 bpm) were demonstrated in the 85 patients. ATP terminated 151 of the 202 episodes (74.8%) in total. The success rate of the ATP was not different among the three groups: 73.3% in Group A, 80.6% in Group B, and 66.7% in Group C. ATP success rate of >50% and >70% was 77.6% and 64.7% of the patients, respectively. Left ventricular ejection fraction (LVEF) was significantly higher in the patients with rather than without successful ATP therapy, and receiver operating characteristic (ROC) analysis revealed that LVEF of 23% was the optimal cut‐off value. ATP was less effective in patients taking amiodarone, but etiology of the structural heart diseases, indication of the device implantation, and all Electrocardiogram (ECG) parameters were not useful predictors for successful ATP therapy. Conclusions ATP highly terminated fast VT with wide HR ranges in patients with structural heart diseases, and should be considered as the first‐line therapy for fast VT except for patients with very low LVEF.

show abstract

Section: Methodsmentioning

confidence: 99%

Patient‐by‐patient basis anti‐tachycardia pacing for fast ventricular tachycardia with structural heart diseases

Chinushi¹,

Furushima²,

Saitoh³

et al. 2020

Pacing Clinical Electrophis

View full text Add to dashboard Cite

show abstract

“…The subjects in this prospective, single‐center study consisted of 34 patients (29 men, age 63 ± 13 years) undergoing ICD implantation (n = 12), CRT‐D implantation (n = 6), or ICD generator exchange (n = 16) between September 2010 and May 2013 at Hyogo College of Medicine. ICDs or CRT‐Ds were implanted in all patients according to the guidelines for Non‐Pharmacotherapy of Cardiac Arrhythmias of the Japanese Circulation Society and guidelines of the American College of Cardiology/American Heart Association/Heart Rhythm Society . Exclusion criteria were: age <18 years, New York Heart Association class IV heart failure, pregnancy (present or suspected), severe anemia, and severe renal dysfunction.…”

Section: Methodsmentioning

confidence: 99%

The Effects of Shock from Defibrillation Threshold Testing on Cardiac Systolic and Diastolic Function

Kodani

Mine

Kishima

et al. 2016

Pacing Clinical Electrophis

View full text Add to dashboard Cite

show abstract

“…RAFT trial12 which enrolled NYHA class II or III heart failure patients showed no statistical difference on the effect of CRT between NYHA classes and established the efficacy of CRT in patients with early stage HF. As shown in Table 1 and Table 2, the current Japanese indications of CRT or CRT‐D are based on the nonpharmacotherapy of arrhythmia by Japanese Society of Cardiology revised in 2011 5. Although the indications for NYHA class II heart failure patients are partially indicated in this guideline, the indications of CRT therapy will expand furthermore in the future based on the recent evidences.…”

Section: Expanding Indication For Crtmentioning

confidence: 99%

“…It is also important to prevent sudden cardiac death due to lethal arrhythmias in HF patients, and CRT with defibrillators (CRT‐D) has been applied in most cases. The indication for CRT or CRT‐D is decided based on the guideline on nonpharmacotherapy for arrhythmias by Japanese Circulation Society and Japanese Heart Rhythm Society published in 2011 5. However, many clinical studies have been demonstrating new evidences on CRT every year and we need to keep up the latest evidences to provide best treatment for the patients 6, 7.…”

Section: Introductionmentioning

confidence: 99%

Up‐to‐date cardiac resynchronization therapy

Okamura

2017

J of Gen and Family Med

View full text Add to dashboard Cite

Cardiac resynchronization therapy (CRT) has been first reported more than 10 years ago as a therapy for patients with severe chronic heart failure. The efficacy of CRT has been proven in many studies that it improves not only quality of life but also the prognosis of the patients. Its indication has been expanded for patients with mild heart failure. On the other hand, some patients cannot receive enough benefit through CRT. The position of the left ventricular lead is limited due to the anatomy of coronary sinus branches, pacing threshold of the myocardium, phrenic nerve stimulation, and so on. Also, the right selection of the candidates for CRT is critical to receive the most benefit of this therapy. The target of this review article is to describe the efficacy and the indication of CRT, which can be of any help to enroll more patients with heart failure who are likely to get benefits through CRT.

show abstract

Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011)

Cited by 135 publications

References 29 publications

Patient‐by‐patient basis anti‐tachycardia pacing for fast ventricular tachycardia with structural heart diseases

Patient‐by‐patient basis anti‐tachycardia pacing for fast ventricular tachycardia with structural heart diseases

The Effects of Shock from Defibrillation Threshold Testing on Cardiac Systolic and Diastolic Function

Up‐to‐date cardiac resynchronization therapy

Contact Info

Product

Resources

About